OPPOSITION PENDING
on 26 Jun 2023
Last Applicant/ Owned by
400 West 61st Street
New York
NY
10069
Serial Number
90798006 filed on 28th Jun 2021
Registration Number
N/A
Correspondent Address
LAUREN GREGORY LEIPOLD
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EMENDOBIO
Testing, research, or development of pharmaceutical preparations for gene therapy; testing, research, selection, optimization or development of nucleases for gene targeting, gene editing, or gene therapy; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; scientific research in the field of genetics, gene editing and genetic engineering; provi Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Testing, research, or development of pharmaceutical preparations for gene therapy; testing, research, selection, optimization or development of nucleases for gene targeting, gene editing, or gene therapy; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; scientific research in the field of genetics, gene editing and genetic engineering; providing medical and scientific research information in the fields of pharmaceuticals and genetics; scientific research consulting in the field of genetics; scientific research consulting in the field of gene editing; scientific research consulting in the field of selection and optimization of nucleases for gene editing and pharmaceutical development; scientific research in the field of selection and optimization of nucleases for gene editing and pharmaceutical development; pharmaceutical research services, excluding production technologies; pharmaceutical research and development, excluding production technologies; pharmaceutical products development; pharmaceutical product evaluation; pharmaceutical drug development services, excluding production technologies; development of pharmaceutical preparations and medicines; technical research in the field of pharmaceutical studies, excluding production technologies; research and development in the pharmaceutical and biotechnology fields, excluding production technologies; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research services in the field of cancer; medical research services in the field of genetic blood disorders; medical research services in the field of genetic ocular disorders; medical and scientific research in the field of cancer treatment and diagnosis; scientific research for medical purposes in the field of gene editing and genetic disorders; scientific research for medical purposes in the field of nuclease and nuclease panel discovery and optimization for the development of gene-targeting pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Enzyme preparations for medical purposes; enzymes for medical purposes; nucleases and nuclease panels for medical purposes; reagents for use in medical genetic testing; preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the prevention of diseases or decisions caused by genetic predispositions; pharmaceutical preparations for editing of faulty genes; chemical preparations for pharmaceutical or medical purposes, namely, for editing of faulty genes; anti-cancer preparations; pharmaceutical products for the prevention and treatment of cancer; ocular pharmaceuticals; pharmaceutical preparations and substances for the treatment of genetic blood disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Enzymes for scientific and research purposes; nucleases and nuclease panels for scientific and research purposes; nucleases and nuclease panels derived from biotechnological processes for use in scientific and research purposes; assays and reagents for use in genetic research; nucleases and nuclease panels for use in genetic research
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90798006
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Jun 2023 | OPPOSITION INSTITUTED NO. 999999 |
| 24th Jan 2023 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 27th Dec 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 27th Dec 2022 | PUBLISHED FOR OPPOSITION |
| 07th Dec 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 22nd Nov 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 03rd Nov 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 03rd Nov 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 03rd Nov 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 03rd May 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |